Benitec Biopharma Inc. (BNTC) has drawn renewed attention following a series of clinical and regulatory developments tied to its gene therapy pipeline. With recent designations from global health authorities and early signs of clinical activity, the company's progress has positioned it as one to monitor in the evolving genetic medicine space.
BB-301 Shows 100% Response Rate
Earlier this month, the company released interim clinical data for its investigational gene therapy candidate BB-301.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.